We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Unit Keeps Generic Cos. At Bay Over Risperdal

Law360 (October 16, 2006, 12:00 AM EDT) -- Blocking two proposed generic versions of an antipsychotic drug, a New Jersey district court has affirmed the validity and enforceability of a Johnson & Johnson unit’s patent for Risperdal.

Judge John...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.